ABBV:TSX, AbbVie CDR (CAD Hedged)
ABBV stock overview
AbbVie CDR (CAD Hedged) (ABBV:TSX) closed at $39.60 on October 23, 2026,
up 0.35% on the day.
The stock trades 1.6% below its 52-week high of $40.26
and 47.3% above its 52-week low of $26.89.
Over the past year, it gained 22.4%.
AbbVie CDR (CAD Hedged) is part of the Health Care sector.
Key figures
- Price
- $39.60
- Day change
- +0.35%
- Volume
- 4,509
- Average volume
- 4,875
- Market cap
- 661B+
- 52-week range
- $26.89 – $40.26
- 50-day average
- $36.82
- 200-day average
- $32.83
Price action over the past year
In 252 trading sessions since October 23, 2025, ABBV closed higher on 132 days (52%).
Its best day was June 22, 2026 (+5.94%) and its worst was March 18, 2026 (-5.09%).
It never moved 10% or more in a single session.
It opened at least 5% above the previous day's high 1 time.
Recent signals
ABBV news
-
Oct 24, 2026:
AbbVie Won FDA Approval for At-Home Skyrizi Starts in Crohn's. Here's When It Should Show Up in Sales
-
Oct 24, 2026:
AbbVie (ABBV) Stock Gets Fair Value Bump After Analyst Target Increases
-
Oct 23, 2026:
U.S. FDA Approves Subcutaneous Induction Regimen for AbbVie's SKYRIZI® (risankizumab-rzaa) for Adults With Moderately to Severely Active Crohn's Disease
-
Oct 23, 2026:
AbbVie's Dividend Survived Humira's Patent Cliff. Will Merck and Amgen's?
-
Oct 23, 2026:
Eli Lilly Gained 10% in a Week to a New 52-Week High. Is There Room to Run?
-
Oct 23, 2026:
Forget Chasing 7% Yields: These 5 Dividend Stocks Offer Something Different
-
Oct 23, 2026:
BMY vs. ABBV: Which Pharma/Biotech Stock Offers More Upside Potential?
-
Oct 23, 2026:
Global Dental Soft Tissue Wound Care Market Size, Share, and Forecast by Product, 2026-2032 | Plug, Tape, and Foam Demand to Drive 11.8% CAGR and a $390 Million Market
About AbbVie CDR (CAD Hedged)
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology, neuroscience and eye care - and products and services in our Allergan Aesthetics portfolio.
Similar stocks
Find more stocks like ABBV with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.